Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
Most K Street leaders say they have concerns about mega-billionaire Elon Musk’s controversial tenure with the Department of Government Efficiency this year.

Musk gets a poor performance review from K Street

Most K Street leaders say they have concerns about mega-billionaire Elon Musk’s controversial tenure with the Department of Government Efficiency this year.

In his 130 days at DOGE, Musk reshaped Washington through major – and often haphazard – cuts to the federal workforce and agency budgets. A majority of K Street leaders, 72%, have concerns with how Musk led DOGE, according to the latest results from the Canvass, conducted in partnership with LSG.

Musk departed the White House at the end of May. Since his exit, President Donald Trump and Musk have had a dramatic falling out.

Musk kicked off an X rampage last week by criticizing the Trump administration and congressional Republicans for the reconciliation bill, calling it “The Big Ugly Bill.”

Republicans have defended their bill as necessary to slash federal spending. However, according to the Congressional Budget Office, the bill could add $2.4 trillion to the debt over the next decade.

Trump punched back by threatening to terminate Musk’s business contracts with the federal government. Musk then called for Trump’s impeachment in a post on X that has since been deleted.

Despite all of this, the Trump administration is still pursuing a $9.4 billion rescissions package that includes cuts pushed by DOGE.

This month’s Canvass was conducted from May 12-30.

Join the Canvass! Are you a senior leader on the Hill or downtown? Help shape the Washington conversation with anonymous insights on the major policy debates dominating Washington. Sign up here if you work on K Street. Click here to sign up if you’re a senior congressional staffer.

— Kenzie Nguyen

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.